Assenagon Asset Management S.A. Uni Qure N.V. Transaction History

Assenagon Asset Management S.A.

$54.1 Billion
Q4 2024

A detailed history of Assenagon Asset Management S.A. transactions in Uni Qure N.V. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 73,571 shares of QURE stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

73,571

Previous 271,346 72.89%

Holding current value

$1.16 Million

Previous $1.34 Million 2.84%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 14, 2025	SELL	$4.54 - $17.73 $897,898 - $3.51 Million	-197,775 Reduced 72.89%	73,571 $1.3 Million
Q3 2024 Oct 23, 2024	BUY	$3.78 - $10.12 $337,932 - $904,727	89,400 Added 49.14%	271,346 $1.34 Million
Q2 2024 Jul 18, 2024	BUY	$4.39 - $5.43 $798,742 - $987,966	181,946 New	181,946 $815,000
Q3 2022 Oct 27, 2022	SELL	$16.98 - $25.54 $1.98 Million - $2.97 Million	-116,397 Reduced 26.04%	330,617 $6.2 Million
Q2 2022 Jul 27, 2022	SELL	$13.15 - $20.45 $25,918 - $40,306	-1,971 Reduced 0.44%	447,014 $8.33 Million
Q1 2022 Apr 25, 2022	BUY	$14.54 - $21.5 $6.53 Million - $9.65 Million	448,985 New	448,985 $8.11 Million
Q4 2021 Feb 01, 2022	SELL	$20.24 - $36.01 $1.88 Million - $3.35 Million	-93,129 Closed	0 $0
Q3 2021 Oct 19, 2021	SELL	$26.01 - $38.22 $5.27 Million - $7.74 Million	-202,620 Reduced 68.51%	93,129 $2.98 Million
Q2 2021 Jul 15, 2021	BUY	$29.97 - $37.17 $8.86 Million - $11 Million	295,749 New	295,749 $9.11 Million
Q4 2020 Feb 01, 2021	SELL	$35.35 - $50.67 $498,717 - $714,852	-14,108 Closed	0 $0
Q3 2020 Oct 07, 2020	BUY	$35.98 - $47.66 $507,605 - $672,387	14,108 New	14,108 $520,000
Q2 2020 Jul 21, 2020	SELL	$45.06 - $67.74 $2.42 Million - $3.63 Million	-53,607 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$40.01 - $73.97 $1.83 Million - $3.39 Million	45,765 Added 583.59%	53,607 $2.54 Million
Q4 2019 Jan 17, 2020	SELL	$37.13 - $74.62 $2.61 Million - $5.25 Million	-70,311 Reduced 89.97%	7,842 $562,000
Q3 2019 Oct 16, 2019	BUY	$39.36 - $76.8 $3.08 Million - $6 Million	78,153 New	78,153 $3.08 Million
Q2 2019 Aug 12, 2019	SELL	$52.76 - $82.19 $440,282 - $685,875	-8,345 Closed	0 $0
Q1 2019 Apr 26, 2019	BUY	$27.39 - $68.41 $228,569 - $570,881	8,345 New	8,345 $498,000

Others Institutions Holding QURE

# of Institutions

152

Shares Held

40.4M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $736M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Uni Qure N.V. Transaction History